Medpace Holdings (MEDP) reported fiscal Q1 earnings late Monday of $3.67 per diluted share, up from $3.20 a year earlier.
Analysts polled by FactSet expected $3.06.
Revenue for the quarter ended March 31 was $558.6 million, up from $511.0 million a year ago. Analysts expected $526.3 million.
For full-year 2025, the company said it now expects EPS of $12.26 to $13.04 on revenue of $2.14 billion to $2.24 billion.
In February, it forecast 2025 EPS of $11.93 to $12.69 on revenue of $2.11 billion to $2.21 billion. Analysts expected EPS of $12.24 on revenue of $2.14 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.